Athletics

WADA says it will not appeal Coleman decision

2019-09-04 12:47
Christian Coleman (Getty Images)

Paris - World anti-doping watchdogs said Wednesday they would not challenge a decision by US anti-doping chiefs to clear sprinter Christian Coleman of alleged doping violations.

US sprinter Coleman, the fastest man over 100m this year, had faced a potential two-year suspension after drug-testers reported they were unable to locate him on three separate occasions in a 12-month period.

However the US Anti-Doping Agency (USADA) dropped the case after determining that the time-frame exceeded the specified one-year period.

The World Anti-Doping Agency (WADA) which monitors anti-doping efforts said it would not appeal the decision as did the Athletics Integrity Unity, set up by the IAAF as an independent body to police doping in track and field.

"WADA will not be appealing this decision," the world agency told AFP, with the AIU saying in a separate statement it would no appeal.

Coleman's whereabouts failures were recorded on June 6 last year, on January 16 this year and April 26.

However Coleman successfully argued that the first missed case should have been backdated to the first day of that quarter -- April 1, 2018 -- meaning the three failures fell outside the required 12-month period.

Read more on:    christian coleman  |  athletics

 

Read News24’s Comments Policy

 
 
Men
Women
Love 2 Meet
Sport24 on Twitter

Follow Sport24 news on Twitter

Featured

The 2018/19 Absa Premiership season is in full swing. Will Mamelodi Sundowns retain their title? Or can one of Kaizer Chiefs, Orlando Pirates, Wits, SuperSport United - or another team perhaps - snatch glory from the Brazilians? Be sure to visit Sport24 for all the latest news!

Latest blogs
Vote

How much of a runner are you?

Twitter Follow Sport24 on Twitter

Facebook "Like" Sport24's Facebook page

WIN Enter and win with Sport24!

BlackBerry Stay in the loop on your BlackBerry

RSS Feeds Sport news delivered really simply.

 
There are new stories on the homepage. Click here to see them.